Dominant negative retinoic acid receptor initiates tumor formation in mice
2006

Retinoic Acid Receptor and Tumor Formation in Mice

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Tara S. Kupumbati, Giorgio Cattoretti, Christine Marzan, Eduardo F. Farias, Reshma Taneja, Rafael Mira-y-Lopez

Primary Institution: Mount Sinai School of Medicine

Hypothesis

Chronic physiological RAR activation by endogenous retinoids may be anti-tumorigenic.

Conclusion

The study suggests that physiological RAR activity may suppress tumor growth in B lymphocytes and mammary epithelial cells.

Supporting Evidence

  • Transgenic mice developed B cell lymphomas at high penetrance.
  • Mammary tumors were not observed in the transgenic mice during the study period.
  • A metastatic mammary adenocarcinoma developed in one of four transplanted glands.

Takeaway

Scientists created special mice to see if a certain protein could stop tumors from growing, and they found that when the protein didn't work, tumors formed.

Methodology

Transgenic mice were created to express a dominant negative RARα, and tumor development was monitored over time.

Limitations

The study's findings are preliminary and require further validation in larger studies.

Participant Demographics

Transgenic mice were used in the study.

Statistical Information

P-Value

0.035

Statistical Significance

p = 0.035

Digital Object Identifier (DOI)

10.1186/1476-4598-5-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication